Debes Hammershaimb Christiansen

Mutations With Loss of Heterozygosity of p53 Are Common in Therapy-Related Myelodysplasia and Acute Myeloid Leukemia After Exposure to Alkylating Agents and Significantly Associated With Deletion or Loss of 5q, a Complex Karyotype, and a Poor Prognosis

Debes Hammershaimb Christiansen, Mette Klarskov Andersen, J Pedersen-Bjergaard · Journal of Clinical Oncology · 2001 · 303 citations

Life Sciences, Genetics, Hematology +17

Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia

J Pedersen-Bjergaard, Mette Klarskov Andersen, Debes Hammershaimb Christiansen et al. · Blood · 2002 · 245 citations · Full text

Medicine, Genetics, Molecular Genetics +16

Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation

J Pedersen-Bjergaard, Mette Klarskov Andersen, Debes Hammershaimb Christiansen · Blood · 2000 · 239 citations

Medicine, Hematology, Oncology +16

Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia

Debes Hammershaimb Christiansen, Mette Klarskov Andersen, J Pedersen-Bjergaard · Leukemia · 2003 · 177 citations

Medicine, Genetics, Molecular Genetics +14

Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation

Debes Hammershaimb Christiansen, Mette Klarskov Andersen, J Pedersen-Bjergaard · Blood · 2004 · 133 citations · Full text

Life Sciences, Genetics, Hematology +15